2003Zhonghua heyixue yu fenzi yingxiang zazhiRequires access

The change of serum TRAb after ~(131)I radiotherapy in patients of Graves'hyperthyroidism

Bangping Cui

Open publisher page 0 citations

Abstract

Objective The clinical value of thyrotrophin receptor antibody(TRAb)in patients with Graves' hyperthyroidism was investigated during ~(131)I radiotherapy.Methods A total of 130 patients with Graves' hyperthyroidism and 50 normal controls were included in the study.Serum concentration of TRAb was measured by radioreceptor assay(RRA)before and at 3,6,12 and 24 months after ~(131)I radio- therapy.Results Abnormally higher TRAb level [(92.93±68.99)U/L] was noted in patients before treatment(P0.O1).The TRAb titer increased further to(139.04±77.19)U/L at 3 months after therapy (P0.01),before it dropped to(65.87±54.86)U/L and(14.16±12.35)U/L at 6 and 12 months re- spectively.At 24 months after ~(131)I radiotherapy,the TRAb [(12.99±5.52)U/L] was back to normal with no difference to that of controls(P0.05).Conclusion Serum concentration of TRAb was of clini- cal significance in the diagnosis of Graves' hyperthyroidism and in the monitoring of ~(131)I radiotherapy.

About this research paper

What this paper is about

Objective The clinical value of thyrotrophin receptor antibody(TRAb)in patients with Graves' hyperthyroidism was investigated during ~(131)I radiotherapy.Methods A total of 130 patients with Graves' hyperthyroidism and 50 normal controls were included in the study.Serum concentration of TRAb was measured by radioreceptor assay(RRA)before and at 3,6,12 and 24 months after ~(131)I radio- therapy.Results Abnormally higher TRAb level [(92.93±68.99)U/L] was noted in patients before treatment(P0.O1).The TRAb titer increased further to(139.04±77.19)U/L at 3 months after therapy (P0.01),before it dropped to(65.87±54.86)U/L and(14.16±12.35)U/L at 6 and 12 months re- spectively.At 24 months after ~(131)I radiotherapy,the TRAb [(12.99±5.52)U/L] was back to normal with no difference to that of controls(P0.05).Conclusion Serum concentration of TRAb was of clini- cal significance in the diagnosis of Graves' hyperthyroidism and in the monitoring of ~(131)I radiotherapy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective The clinical value of thyrotrophin receptor antibody(TRAb)in patients with Graves' hyperthyroidism was investigated during ~(131)I radiotherapy.Methods A total of 130 patients with Graves' hyperthyroidism and 50 normal controls were included in the study.Serum concentration of TRAb was measured by radioreceptor assay(RRA)before and at 3,6,12 and 24 months after ~(131)I radio- therapy.Results Abnormally higher TRAb level [(92.93±68.99)U/L] was noted in patients before treatment(P0.O1).The TRAb titer increased further to(139.04±77.19)U/L at 3 months after therapy (P0.01),before it dropped to(65.87±54.86)U/L and(14.16±12.35)U/L at 6 and 12 months re- spectively.At 24 months after ~(131)I radiotherapy,the TRAb [(12.99±5.52)U/L] was back to normal with no difference to that of controls(P0.05).Conclusion Serum concentration of TRAb was of clini- cal significance in the diagnosis of Graves' hyperthyroidism and in the monitoring of ~(131)I radiotherapy.

Key concepts: Trab, Medicine, Graves' disease, Titer, Radiation therapy, Internal medicine, Endocrinology, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
The change of serum TRAb after ~(131)I radiotherapy in patients of Graves'hyperthyroidism — Research Paper | ScholarLens